Ember LifeSciences
Ember LifeSciences is a leading provider of revolutionary cold chain technology, leveraging proprietary temperature control technology to improve the transportation of life-saving medicines and vaccines globally. Initially launched as an offshoot of Ember Technologies, the company aims to redefine global medicine distribution through innovative solutions.
Leadership & Board
- Current Number of Employees
- 28
- Current LinkedIn Followers
- 1,413
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $44M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $27M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
Ember LifeSciences had 28 employees as of October 12, 2026. The number of employees increased by 1 (3.70%) week-over-week.
28Latest Employee Count
1(3.70%)Week-Over-Week Change
Social Trend
Ember LifeSciences had 1,413 followers as of October 12, 2026. The number of followers increased by 3 (0.21%) week-over-week.
1,413Latest Followers Count
3(0.21%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| May 27, 2026 | Series A | $27.00M | ― |
| Dec 16, 2025 | Series A | $16.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Amgen Ventures | Series A |
| TDF Ventures | Series A |
| Sea Court Capital | Series A |
| Cardinal Health | Series A |
| Carrier Ventures | Series A |
| Mike Pompeo | Series A |
Similar Companies
A snapshot of private companies similar to Ember LifeSciences, helping you discover and navigate related company profiles.
Related News and Analysis
